Last updated: February 22, 2024
Sponsor: Central Hospital, Nancy, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Systemic Fungal Infections
Treatment
biomarkers
Clinical Study ID
NCT04937751
2020PI202
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Suspicion of invasive fungal infection involving the performance of a blood culture ora skin biopsy or diagnosis of keratitis involving the taking of a cornea sample
- Fungal culture carried out on this sample
- Person having been informed of the research and not having opposed the use of theirdata
Exclusion
Exclusion Criteria:
- Clinical diagnosis of superficial fusarium wilt (onychomycosis, etc.)
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: biomarkers
Phase:
Study Start date:
July 19, 2023
Estimated Completion Date:
July 31, 2028
Connect with a study center
CHRU Nancy
Vandoeuvre les nancy, 54500
FranceActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.